US Patent Dispute Simmers Over Treprostinil-based Therapies for PAH
News, PAH News
U.S. specialty biopharmas SteadyMed and United Therapeutics both issued media releases recently commenting on a ruling by the U.S. Patent and Trademark Office (USPTO) that declared invalid a United Therapeutics patent related ... Read more